Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study
María Auxiliadora Bajo; Francisco Ríos-Moreno; Maria Dolores Arenas; Ramón Jesús Devesa-Such; Maria Jose Molina-Higueras; Margarita Delgado; Pablo Molina; Nuria García-Fernández; Alejandro Martin-Malo; Roser Peiró-Jordán; Jorge Cannata-Andia; Ángel Luis Martín-De Francisco;
Nefrologia (English Version). 2022;42:594-606
Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study
J. Emilio Sanchez-Alvarez; Elena Astudillo Cortés; Miguel Seras Mozas; Raúl García Castro; Carlos Miguel Hidalgo Ordoñez; Ana Cristina Andrade López; Catalina Ulloa Clavijo; Anna Gallardo Pérez; Carmen Rodríguez Suarez;
Nefrologia (English Version). 2021;41:45-52
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;
Nefrologia (English Version). 2023;43 Supl 1:1-36